Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medical Facilities ( (TSE:DR) ) has shared an update.
Medical Facilities Corporation announced it will release its third quarter 2025 financial results on November 6, 2025, before the market opens. The company will host an earnings conference call to discuss the results, providing stakeholders with insights into its financial performance. This announcement is significant as it offers an opportunity for investors and analysts to evaluate the company’s operational and financial health, potentially impacting its market positioning and stakeholder decisions.
The most recent analyst rating on (TSE:DR) stock is a Hold with a C$15.50 price target. To see the full list of analyst forecasts on Medical Facilities stock, see the TSE:DR Stock Forecast page.
Spark’s Take on TSE:DR Stock
According to Spark, TipRanks’ AI Analyst, TSE:DR is a Neutral.
Medical Facilities’ overall score is driven by strong profitability and an attractive valuation, offset by declining revenue and cash flow growth. The technical indicators suggest potential bearish momentum, while the earnings call highlighted both achievements and challenges, particularly related to Sioux Falls. The low P/E ratio and dividend yield offer value, but operational challenges need addressing.
To see Spark’s full report on TSE:DR stock, click here.
More about Medical Facilities
Medical Facilities Corporation, in partnership with physicians, owns a portfolio of highly rated surgical facilities in the United States. The company holds controlling interests in three specialty surgical hospitals in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center in California. These facilities perform scheduled surgical, imaging, diagnostic, and other procedures, generating revenue from facility usage fees.
Average Trading Volume: 28,650
Technical Sentiment Signal: Buy
Current Market Cap: C$269.1M
For a thorough assessment of DR stock, go to TipRanks’ Stock Analysis page.

